The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications
Open accessAbstract
BACKGROUND: Obesity is associated with low-grade chronic inflammation, and serum markers of inflammation are independent risk factors for cardiovascular disease (CVD). However, the molecular and cellular mechanisms that link obesity to chronic inflammation and CVD are poorly understood. METHODS AND FINDINGS: Acute-phase serum amyloid A (A-SAA) mRNA levels, and A-SAA adipose secretion and serum levels were measured in obese and nonobese individuals, obese participants who underwent weight-loss, and persons treated with the insulin sensitizer rosiglitazone. Inflammation-eliciting activity of A-SAA was investigated in human adipose stromal vascular cells, coronary vascular endothelial cells and a murine monocyte cell line. We demonstrate that A-SAA was highly and selectively expressed in human adipocytes. Moreover, A-SAA mRNA levels and A-SAA secretion from adipose tissue were significantly correlated with body mass index (r = 0.47; p = 0.028 and r = 0.80; p = 0.0002, respectively). Serum A-SAA levels decreased significantly after weight loss in obese participants (p = 0.006), as well as in those treated with rosiglitazone (p = 0.033). The magnitude of the improvement in insulin sensitivity after weight loss was significantly correlated with decreases in serum A-SAA (r = -0.74; p = 0.034). SAA treatment of vascular endothelial cells and monocytes markedly increased the production of inflammatory cytokines, e.g., interleukin (IL)-6, IL-8, tumor necrosis factor alpha, and monocyte chemoattractant protein-1. In addition, SAA increased basal lipolysis in adipose tissue culture by 47%. CONCLUSIONS: A-SAA is a proinflammatory and lipolytic adipokine in humans. The increased expression of A-SAA by adipocytes in obesity suggests that it may play a critical role in local and systemic inflammation and free fatty acid production and could be a direct link between obesity and its comorbidities, such as insulin resistance and atherosclerosis. Accordingly, improvements in systemic inflammation and insulin resistance with weight loss and rosiglitazone therapy may in part be mediated by decreases in adipocyte A-SAA production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 2×
“In addition, obesity is associated with increased infiltration of adipose tissue by macrophages [10,11], which may also be target cells of SAA action.”
BackgroundAcute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“, C-reactive protein, and based on animal studies, the liver is thought to be the primary source of circulating A-SAA [35].”
BackgroundPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 2×
“This constellation of obesity-related complications, often referred to as the metabolic syndrome or syndrome X [1,2], markedly increases risk of cardiovascular disease (CVD) and death [3,4].”
BackgroundRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 3×
“Modest elevation in CRP is associated with increased CVD risk in epidemiological studies [5,57,58].”
BackgroundCardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,028
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“The same signaling pathway recently has been shown to be an important mediator of inflammationassociated insulin resistance [47,48].”
BackgroundKoenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Self-citationMonocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Flier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,112
A, P. T., A, M. G., & W, A. R. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 1,024
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 912
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty
Shimomura, I., Funahasm, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-800 · Cited by 890
Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B., Bairey Merz, C. N., Sopko, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115516.54550.b1 · Cited by 414
An enzymatic fluorometric micromethod for the determination of glycerol
Laurell, S., & Tibbling, G. (1966) · Clinica Chimica Acta · doi:10.1016/0009-8981(66)90210-5 · Cited by 410
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 379
Serum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329
Adipose tissue, insulin action and vascular disease: inflammatory signals
Yudkin, J. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802496 · Cited by 311 · cited 1×
“Increasing evidence supports the hypothesis that the lowgrade chronic systemic inflammation associated with obesity may be an important mediator of the metabolic syndrome and its constituents, including insulin resistance, type 2 diabetes, dyslipidemia, and hypertension [29–31].”
BackgroundHyperglycemia-induced Production of Acute Phase Reactants in Adipose Tissue
Lin, Y., Rajala, M. W., Berger, J. P., Moller, D. E., Barzilai, N., & Scherer, P. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107101200 · Cited by 254
Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Production in Vitro
Trujillo, M. E., Sullivan, S., Harten, I., Schneider, S. H., Greenberg, A. S., & Fried, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0603 · Cited by 248
Self-citationvan Dielen, F., van't Veer, C., Schols, A., Soeters, P., Buurman, W., & Greve, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801825 · Cited by 230
Furlaneto, C. J., & Campa, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2143 · Cited by 223
Ryan, A. S., & Nicklas, B. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1699 · Cited by 210
Self-citationTNFα release by the nonfat cells of human adipose tissue
Fain, J. N., Bahouth, S. W., & Madan, A. K. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802594 · Cited by 203
Wu, A., Hinds, C. J., & Thiemermann, C. (2004) · Shock · doi:10.1097/01.shk.0000111661.09279.82 · Cited by 199
Souza, S. C., Palmer, H. J., Kang, Y., Yamamoto, M. T., Muliro, K. V., Eric Paulson, K., & Greenberg, A. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10565 · Cited by 185
Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T., Csako, G., Thomas, F., Eggerman, T. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405009200 · Cited by 184
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition
Poitou, C., Viguerie, N., Cancello, R., De Matteis, R., Cinti, S., Stich, V., Coussieu, C., Gauthier, E., Courtine, M., Zucker, J. D., et al. (2005) · Diabetologia · doi:10.1007/s00125-004-1654-6 · Cited by 180
Hsueh, W. C., Mitchell, B. D., Aburomia, R., Pollin, T., Sakul, H., Gelder Ehm, M., Michelsen, B. K., Wagner, M. J., St Jean, P. L., Knowler, W. C., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.595 · Cited by 172
Self-citationWhitehead, A. S., de Beer, M. C., Steel, D. M., Rits, M., Lelias, J. M., Lane, W. S., & de Beer, F. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50605-6 · Cited by 171
Diabesity: An Inflammatory Metabolic Condition
Schmidt, M. I., & Duncan, B. B. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.174 · Cited by 164
Fried, S. K., & Zechner, R. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38211-0 · Cited by 162
Self-citationSjöholm, K., Palming, J., Olofsson, L. E., Gummesson, A., Svensson, P.-A., Lystig, T. C., Jennische, E., Brandberg, J., Torgerson, J. S., Carlsson, B., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1830 · Cited by 159
Lehrke, M., & Lazar, M. A. (2004) · Nature Medicine · doi:10.1038/nm0204-126 · Cited by 138
O’Brien, K. D., Brehm, B. J., Seeley, R. J., Bean, J. A., Wener, M. H., Daniels, S. R., & D’Alessio, D. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1011 · Cited by 138
Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease
Hsueh, W. A., & Bruemmer, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000113626.76571.5b · Cited by 137
Nonexpression of the Human Serum Amyloid A Three (SAA3) Gene
Kluve‐Beckerman, B., Drumm, M. L., & Benson, M. D. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.651 · Cited by 122
Control of lipolysis and its relevance to development of obesity in man
Amer, P. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040507 · Cited by 122
Jousilahti, P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00681-x · Cited by 120
Thorn, C. F., Lu, Z. ‐., & Whitehead, A. S. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01369.x · Cited by 110
Lavau, M. M., Susini, C., Knittle, J. L., Blanchet-Hirst, S., & Greenwood, M. R. C. (1977) · Experimental Biology and Medicine · doi:10.3181/00379727-156-39916 · Cited by 97
A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease
Ogasawara, K., Mashiba, S., Wada, Y., Sahara, M., UCHIDA, K., Aizawa, T., & Kodama, T. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.030 · Cited by 82
mRNA expression and release of interleukin‐8 induced by serum amyloid A in neutrophils and monocytes
Ribeiro, F. P., Furlaneto, C. J., Hatanaka, E., Ribeiro, W. B., Souza, G. M., Cassatella, M. A., & Čampa, A. (2003) · Mediators of Inflammation · doi:10.1080/0962935031000134897 · Cited by 80
Insulin resistance in adipocytes of obese women: Effects of body fat distribution and race
Dowling, H. J., Fried, S. K., & Pi-Sunyer, X. (1995) · Metabolism · doi:10.1016/0026-0495(95)90094-2 · Cited by 77
Self-citationHatanaka, E., Furlaneto, C. J., Ribeiro, F. P., Souza, G. M., & Čampa, A. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.011 · Cited by 64
Cited by
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Metadata
- Authors
- Yang, R.-Z., Lee, M.-J., Hu, H., Pollin, T. I., Ryan, A. S., Nicklas, B. J., Snitker, S., Horenstein, R. B., Hull, K., Goldberg, N. H., Goldberg, A. P., Shuldiner, A. R., Fried, S. K., & Gong, D.-W.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-06-06
- Volume
- 3
- Issue
- 6
- Pages
- e287
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2078355311
- Cited by
- 355
- References
- 57
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.